506104 | p21WAF1, GST-Fusion, Human, Recombinant, E. coli

506104
  
Retrieving price...
Price could not be retrieved
Minimum Quantity needs to be mulitiple of
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited AvailabilityLimited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service

       

      Contact Customer Service

      Click To Print This Page

      Overview

      Replacement Information
      Description
      Overview

      This product has been discontinued.





      Full-length, recombinant, human p21WAF1 fused at the N-terninus to GST and expressed in E. coli. p21WAF1 is a transcriptional target of p53 and an inhibitor of cyclin dependent kinases, particularly Cdk2. Useful for protein binding and kinase inhibition assays.
      Catalogue Number506104
      Brand Family Calbiochem®
      Synonymsp21CIP1, Human, Recombinant
      References
      ReferencesWagner, M., et al. 2001. Anticancer Res. 21,333.
      el-Deiry, W.S., et al. 1994. Cancer Res. 54,1169.
      Product Information
      FormLiquid
      FormulationIn 150 mM NaCl, 50 mM Tris-HCl, 0.25 mM DTT, 0.1 mM PMSF, 25% glycerol, pH 7.5.
      Applications
      Biological Information
      Purity≥80% by SDS-PAGE
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Dry Ice Only
      Toxicity Standard Handling
      Storage -70°C Freezer
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      Certificates of Analysis

      TitleLot Number
      506104

      References

      Reference overview
      Wagner, M., et al. 2001. Anticancer Res. 21,333.
      el-Deiry, W.S., et al. 1994. Cancer Res. 54,1169.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision18-April-2008 JSW
      Synonymsp21CIP1, Human, Recombinant
      DescriptionFull-length, recombinant, human p21WAF1 fused at the N-terninus to GST and expressed in E. coli. p21WAF1 is a transcriptional target of p53 and an inhibitor of cyclin dependent kinases, particularly Cdk2. Useful for protein binding and kinase inhibition assays.
      FormLiquid
      FormulationIn 150 mM NaCl, 50 mM Tris-HCl, 0.25 mM DTT, 0.1 mM PMSF, 25% glycerol, pH 7.5.
      Concentration Label Please refer to vial label for lot-specific concentration
      Purity≥80% by SDS-PAGE
      Storage -70°C Freezer
      Avoid freeze/thaw
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
      Toxicity Standard Handling
      ReferencesWagner, M., et al. 2001. Anticancer Res. 21,333.
      el-Deiry, W.S., et al. 1994. Cancer Res. 54,1169.